Jun 23, 2026 08:31AM
Jun 18, 2026 08:31AM
Jun 16, 2026 08:31AM
Jun 4, 2026 08:31AM
Jun 2, 2026 08:31AM
May 4, 2026 06:08AM
Apr 28, 2026 08:32AM Quoin Pharmaceuticals plans investigator-led studies for QRX009
Mar 11, 2026 08:30AM
Jan 27, 2026 08:31AM
Nov 11, 2025 08:31AM
Oct 28, 2025 08:31AM
Oct 21, 2025 08:30AM
Aug 7, 2025 09:40AM
Jul 29, 2025 08:30AM QNRX advances Netherton Syndrome drug in two pivotal studies
Jun 24, 2025 08:34AM
May 22, 2025 07:31AM
May 14, 2025 07:30AM
Apr 30, 2025 07:31AM
Mar 25, 2025 07:31AM
Mar 4, 2025 07:30AM
Feb 27, 2025 07:31AM Quoin Pharmaceuticals (QNRX) Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan 23, 2025 05:30AM
Jan 14, 2025 08:34AM
Jan 6, 2025 08:33AM
Dec 20, 2024 09:20AM
Dec 18, 2024 08:18AM
Nov 5, 2024 08:02AM
Oct 22, 2024 08:01AM Quoin Pharmaceuticals Ltd (QNRX) Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
Sep 9, 2024 08:33AM
Jun 12, 2024 08:14AM

418,853 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All